Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective Study
TACE联合乐伐替尼和PD-1抑制剂治疗不可切除肝细胞癌转化治疗的真实世界疗效和安全性(GUIDANCE007):一项多中心回顾性研究
期刊:Liver Cancer
影响因子:10.500
doi:10.1159/000552409
Ye, Lin; Liu, Guo-Xing; Yang, Da-Long; Zeng, Fan-Jian; Liu, Jie; Yao, Hong-Bing; Nong, Jun-Liang; Liu, Shao-Ping; Peng, Ning; Li, Wen-Feng; Wu, Pei-Sheng; Qin, Chuang; Su, Ze; Ou, Jun-Jie; Dong, Xiao-Feng; Yan, Yi-He; Zhong, Teng-Meng; Wu, Ming-Song; Chen, Yao-Zhi; Wang, Guo-Dong; Li, Mian-Jing; Wang, Xue-Yao; Yang, Fu-Quan; Chen, Shu-Chang; Yang, Yong-Yu; Chen, Kang; Lai, Yong-Cheng; Pang, Qing-Qing; Liang, Xiu-Mei; Mao, Xian-Shuang; Liang, Yong-Rong; Li, Fu-Xin; Shi, Hao; Li, Ren-Jian; Xiang, Bang-De; Ma, Liang; Zhong, Jian-Hong; Yu, Ya-Qun